Signition LP’s Gilead Sciences GILD Stock Holding History

Signition LP’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,458	Closed	-$225K	–	190
2019 Q1	$225K	Buy	+3,458	New	+$230K	0.15%	136

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Signition LP's GILD Position: Q2 2019 in Review

Signition LP sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 3,458 shares — an estimated $225K sold.

Signition LP first reported a position in GILD in Q1 2019 and held it in 1 quarter. The position peaked at $225K in Q1 2019. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

Signition LP reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
Signition LP sold 3,458 Gilead Sciences shares in Q2 2019, an estimated $225K.
Signition LP first reported a position in Gilead Sciences in Q1 2019 and held it in 1 quarter.
Signition LP's Gilead Sciences position peaked at $225K in Q1 2019.
1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Signition LP's 13F filing for Q2 2019, filed 6 Aug 2019.